| UniProt/SwissProt ID: | TEBP_HUMAN |
| Description: | prostaglandin E synthase 3 (cytosolic) [Source:HGNC Symbol;Acc:16049] |
| Location: | chr12 q13.3 |
| Node attribute: | substrate |
|
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|
| S85 | GESGQsWPRLT | | PhosphoSitePlus; HPRD |
| S113 | DWEDDsDEDMS | Pkinase_C | PhosphoSitePlus; SysPTM |
| S113 | DWEDDsDEDMS | | HPRD; phosphoELM; RegPhos; SysPTM |
| S118 | SDEDMsNFDRF | CK2a1(CK2 alpha | RegPhos; SysPTM |
| S124 | NFDRFsEMMNN | | HPRD |
| S148 | GADDDsQDSDD | Pkinase_C | PhosphoSitePlus; SysPTM |
| S124 | NFDRFsEMMNN | Pkinase_C | PhosphoSitePlus |
| S118 | SDEDMsNFDRF | CK2_alpha | phosphoELM; SysPTM |
| S148 | GADDDsQDSDD | | HPRD; phosphoELM; RegPhos; SysPTM |
| S151 | DDSQDsDDEKM | Pkinase_C | PhosphoSitePlus; SysPTM |
| S118 | SDEDMsNFDRF | Pkinase_C | PhosphoSitePlus; SysPTM |
| S100 | KLNWLsVDFNN | | HPRD |
| S151 | DDSQDsDDEKM | | HPRD; phosphoELM; RegPhos; SysPTM |
| S113 | DWEDDsDEDMS | CK2_alpha | phosphoELM; SysPTM |
| Y14 | YDRRDyVFIEF | CS | PhosphoSitePlus |
| S118 | SDEDMsNFDRF | | HPRD; phosphoELM; RegPhos; SysPTM |
| S113 | DWEDDsDEDMS | CK2a1(CK2 alpha | RegPhos; SysPTM |
|
TEBP_HUMAN do not have dephosphorylation site.
|
|
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|
| ENSP00000262033 | H66P | BIOMART | Pancreatic Cancer | 21930507, 21930502 |
|
| Ensembl ID | Cancer name | Design | Sample | Change | Ratio | Pubmed |
|---|
| ENSP00000262033 | Prostate Cancer | Metastasis | cell line | Down | 0.14 | 15102926 |
| ENSP00000262033 | Prostate Cancer | Metastasis | tissue | Up | 3.1 | 18553995 |
| ENSP00000262033 | Hepatocellular Carcinoma | Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) | tissue | Down | | 17593366 |
| ENSP00000262033 | Breast Cancer | Normal vs. Cancer | cell line | Up | 1.6 | 20052998 |
| ENSP00000262033 | Breast Cancer | Normal vs. Cancer | cell line | Up | 1.2 | 20052998 |
| ENSP00000262033 | Breast Cancer | Metastasis | cell line | Down | 0.72 | 20052998 |
| ENSP00000262033 | Neoplasms by Histologic Type | Treatment (none vs. SB203580 treatment 21 hour) | cell line | Up | 1.8 | 15169874 |
| ENSP00000262033 | Uterine Cancer | Treatment (none vs. Suberonylanilide hydroxamic acid (SAHA) treatment) | cell line | Up | | 19179759 |
|
| TEBP_HUMAN do not have hyperphosphorylation site. |
|
| GO ID | GO_Term | Evidence | Ontology |
|---|
| GO:0070389 | chaperone cofactor-dependent protein refolding | IDA | biological_process |
| GO:0051082 | unfolded protein binding | IDA | molecular_function |
| GO:0005829 | cytosol | TAS | cellular_component |
| GO:0005737 | cytoplasm | IDA | cellular_component |
| GO:0005634 | nucleus | IDA | cellular_component |
| GO:0000723 | telomere maintenance | TAS | biological_process |
| GO:0001516 | prostaglandin biosynthetic process | IEA | biological_process |
| GO:0050220 | prostaglandin-E synthase activity | IDA | molecular_function |
| GO:0005697 | telomerase holoenzyme complex | IDA | cellular_component |
| GO:0000781 | chromosome, telomeric region | IC | cellular_component |
| GO:0007165 | signal transduction | TAS | biological_process |
| GO:0003720 | telomerase activity | IDA | molecular_function |
| GO:0005515 | protein binding | IPI | molecular_function |
|
Fatal error: Uncaught Error: Call to undefined function mysql_close() in /usr/local/apache/htdocs/PhoSigNet/include/locateconfig.inc.php:23
Stack trace:
#0 /usr/local/apache/htdocs/PhoSigNet/proteintable.php(435): db_disconnect(Object(mysqli))
#1 {main}
thrown in
/usr/local/apache/htdocs/PhoSigNet/include/locateconfig.inc.php on line
23